|
DK164642C
(da)
*
|
1984-08-30 |
1992-12-14 |
Merrell Dow Pharma |
Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
|
|
EP0212875A3
(en)
*
|
1985-08-12 |
1988-06-15 |
William Gough Tucker |
Medicinal composition and method of making same
|
|
US5112619A
(en)
*
|
1985-11-12 |
1992-05-12 |
Eli Lilly And Company |
Orally administerable sustained release pharmaceutical formulation
|
|
FR2605223B1
(fr)
*
|
1986-10-20 |
1989-09-22 |
Pf Medicament |
Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation
|
|
GB8701332D0
(en)
*
|
1987-01-21 |
1987-02-25 |
Lilly Industries Ltd |
Capsule filling
|
|
DE3702029A1
(de)
*
|
1987-01-24 |
1988-08-04 |
Basf Ag |
Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
|
|
IL87219A0
(en)
*
|
1987-08-07 |
1988-12-30 |
Abbott Lab |
Erythromycin formulations for oral administration
|
|
DE3738236A1
(de)
*
|
1987-11-11 |
1989-05-24 |
Euro Celtique Sa |
Beisskapsel
|
|
US6007840A
(en)
*
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
|
KR0148748B1
(ko)
*
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
|
GB8904182D0
(en)
*
|
1989-02-23 |
1989-04-05 |
Glaxo Canada |
Pharmaceutical compositions
|
|
DE3919982A1
(de)
*
|
1989-06-19 |
1990-12-20 |
Liedtke Pharmed Gmbh |
Orale lipidarzneiform
|
|
US5532002A
(en)
*
|
1989-08-17 |
1996-07-02 |
Cortecs Limited |
Gelatin pharmaceutical formulations
|
|
WO1991002520A1
(en)
*
|
1989-08-17 |
1991-03-07 |
Cortecs Limited |
Pharmaceutical formulations
|
|
WO1992017166A1
(en)
*
|
1991-04-08 |
1992-10-15 |
Nippon Shinyaku Co., Ltd. |
Capsule
|
|
US6262022B1
(en)
|
1992-06-25 |
2001-07-17 |
Novartis Ag |
Pharmaceutical compositions containing cyclosporin as the active agent
|
|
EP0642332B1
(en)
|
1992-05-13 |
1997-01-15 |
Sandoz Ltd. |
Ophthalmic compositions containing a cyclosporin
|
|
PT589843E
(pt)
|
1992-09-25 |
2002-04-29 |
Novartis Ag |
Composicoes farmaceuticas contendo ciclosporinas
|
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
|
ES2308955T5
(es)
|
1993-09-28 |
2012-04-03 |
R.P. Scherer Gmbh |
Fabricación de cápsulas de gelatina blanda
|
|
JPH09510182A
(ja)
*
|
1993-11-17 |
1997-10-14 |
エルディーエス・テクノロジーズ・インコーポレーテッド |
カプセル封入されたドラッグデリバリー用透明液
|
|
GB9405304D0
(en)
*
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
|
DK0789580T3
(da)
|
1994-11-03 |
2002-09-09 |
Novartis Ag |
Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
|
|
US5587149A
(en)
*
|
1995-02-06 |
1996-12-24 |
R.P. Scherer Corporation |
Topical application emulsions
|
|
DE19549852B4
(de)
|
1995-11-29 |
2009-06-04 |
Novartis Ag |
Cyclosporin enthaltende Präparate
|
|
FR2756736B1
(fr)
*
|
1996-12-05 |
1999-03-05 |
Sanofi Sa |
Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
|
|
SG115386A1
(en)
|
1997-01-30 |
2005-10-28 |
Novartis Ag |
Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
|
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
IL129102A0
(en)
*
|
1999-03-22 |
2000-02-17 |
J P M E D Ltd |
An emulsion
|
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
FR2798078B1
(fr)
*
|
1999-09-06 |
2001-10-12 |
Oreal |
Organogel, comprenant un compose hydrophile sensible a l'oxydation et ses utilisations notamment cosmetiques
|
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
|
JP5296314B2
(ja)
*
|
2003-07-17 |
2013-09-25 |
バナー ファーマキャップス，インコーポレイティド |
制御放出製剤
|
|
WO2006024620A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Akzo Nobel N.V. |
Method for pigment solubilisation, a pigment composition and its use
|
|
CN101583273A
(zh)
*
|
2005-07-22 |
2009-11-18 |
加利福尼亚大学董事会 |
肝素组合物和选择素抑制
|
|
US8920918B2
(en)
*
|
2005-10-31 |
2014-12-30 |
Kee Action Sports Technology Holdings, Llc |
Oil and polyethylene glycol fill material for use in paintball shells
|
|
GB0601498D0
(en)
|
2006-01-25 |
2006-03-08 |
Probio Nutraceuticals As |
Product
|
|
GB0818473D0
(en)
|
2008-10-08 |
2008-11-12 |
Probio Nutraceuticals As |
Composition
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9149045B2
(en)
|
2010-12-07 |
2015-10-06 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical emulsion having antimicrobial properties
|
|
US8524264B2
(en)
|
2010-12-07 |
2013-09-03 |
Kimberly-Clark Worldwide, Inc. |
Protein stabilized antimicrobial composition formed by melt processing
|
|
US10821085B2
(en)
|
2010-12-07 |
2020-11-03 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical composition having antimicrobial properties
|
|
US9648874B2
(en)
|
2010-12-07 |
2017-05-16 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple use and re-use, user saturated wipes
|
|
US9832993B2
(en)
|
2010-12-07 |
2017-12-05 |
Kimberly-Clark Worldwide, Inc. |
Melt processed antimicrobial composition
|
|
US8445032B2
(en)
|
2010-12-07 |
2013-05-21 |
Kimberly-Clark Worldwide, Inc. |
Melt-blended protein composition
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
JP5973204B2
(ja)
*
|
2011-03-30 |
2016-08-23 |
興和株式会社 |
カフェイン含有液状組成物及び該組成物を充填したカプセル剤
|
|
US8574628B2
(en)
|
2011-12-19 |
2013-11-05 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple release and re-use compositions
|
|
BR112014029131B1
(pt)
*
|
2012-05-31 |
2021-03-09 |
Allergan Pharmaceuticals International Limited |
cápsula de mucoadesivo
|
|
CA2902171A1
(en)
*
|
2013-02-22 |
2014-08-28 |
Stiefel Laboratories, Inc. |
Non-aqueous solid stabilized emulsions
|
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
EP3544614A4
(en)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
ORAL TESTOSTERONE UNDECANOATE THERAPY
|
|
CN115969807B
(zh)
*
|
2023-01-17 |
2023-09-19 |
青岛双鲸药业股份有限公司 |
一种含生物活性成分的软胶囊内容物及其制备方法
|